Innovation Health Self-Assessment

A compact, repeatable interactive assessment that surfaces capability gaps, operational blockers, and prioritized 90-day actions to strengthen discovery, experimentation, and adoption.

Interactive Tool

Innovation Health Self-Assessment

Use this compact, repeatable assessment to quickly surface the highest-impact risks and opportunities that affect your team's ability to discover, experiment, and deliver innovations. Complete the scales honestly, then capture the top gaps and commit to 1–3 clear 90-day actions. Plan to run this assessment quarterly and use saved responses to measure progress.

How scoring works

Each statement uses a 1–5 scale: 1 = Strongly disagree / Very weak, 3 = Mixed / Inconsistent, 5 = Strong / Consistent. After submission, review your dimension averages and the gap notes to choose prioritized, practical next steps.

Who is completing this assessment (team or unit)?
YYYY-MM-DD (or a simple date string)
Optional: choose the reporting period for this assessment.
1 = No clear vision; 5 = Clear, communicated, and acted upon
1.0 10.0
Senior leaders allocate time, budget or influence when needed.
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1.0 10.0
1 = Not confident; 5 = Very confident
1.0 10.0
List the three most important gaps surfaced by this assessment (one per line).
Use the action template below or list actions directly. Use separate lines for separate actions. You will also be prompted to add owners and success measures.
YYYY-MM-DD or Week/Month
Yes means you agree to schedule a follow-up and track progress.
Use this to request help, ask for templates, or flag risks.
You can explore this tool now. Sign in or create an account to save your responses and return to them later.
Make this tool part of your work

Save a personal copy, bring it to your team, or tailor the questions and workflow to fit what you are hungry to improve.

Member customization and team collaboration are coming soon.

Discussion

Comments and conversation will live here.